Adaptive 3DCNN-Based Interpretable Ensemble Model for Early Diagnosis of Alzheimer's Disease
An adaptive interpretable ensemble model based on a 3-D convolutional neural network (3DCNN) and genetic algorithm (GA), i.e., 3DCNN+EL+GA, was proposed to differentiate the subjects with Alzheimer's disease (AD) or mild cognitive impairment (MCI) and also identify the discriminative brain regi...
Saved in:
Published in | IEEE transactions on computational social systems Vol. 11; no. 1; pp. 247 - 266 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
IEEE
01.02.2024
The Institute of Electrical and Electronics Engineers, Inc. (IEEE) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | An adaptive interpretable ensemble model based on a 3-D convolutional neural network (3DCNN) and genetic algorithm (GA), i.e., 3DCNN+EL+GA, was proposed to differentiate the subjects with Alzheimer's disease (AD) or mild cognitive impairment (MCI) and also identify the discriminative brain regions significantly contributing to the classifications in a data-driven way. The testing results on the datasets from both the AD Neuroimaging Initiative (ADNI) and the Open Access Series of Imaging Studies (OASIS) indicated that 3DCNN+EL+GA outperformed other state-of-the-art deep learning algorithms. More importantly, in these identified brain regions, the discriminative brain subregions at a voxel level were further located with a gradient-based attribution method designed for CNN and illustrated intuitively. Besides these, the behavioral domains corresponding to every identified discriminative brain region (e.g., the rostral hippocampus) were analyzed. It was shown that the resultant behavioral domains were consistent with those brain functions (e.g., emotion) impaired early in the AD process. Further research is needed to examine the generalizability of the proposed ideas and methods in identifying discriminative brain regions and subregions for the diagnosis of other brain disorders (especially little-known ones), such as Parkinson's disease, epilepsy, severe depression, autism, Huntington's disease, multiple sclerosis, and amyotrophic lateral sclerosis, using neuroimaging. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Author Contributions Statement DP and AZ designed and coordinated the study. GL, CZ, HL, JW, TZ, DP, AZ and BY carried out experiments and data processes. DP, GL, and AZ reviewed the study design and data processing, and edited the result presentation and interpretation. All authors drafted and revised the manuscript and approved the submission of the final version of the manuscript. |
ISSN: | 2329-924X 2373-7476 |
DOI: | 10.1109/TCSS.2022.3223999 |